All Stories

  1. Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities
  2. Comorbidity Patterns in Patients with Atopic Dermatitis Using Network Analysis in the EpiChron Study
  3. Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort
  4. Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP study
  5. How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention
  6. Multimorbidity Profiles and Infection Severity in COVID-19 Population Using Network Analysis in the Andalusian Health Population Database
  7. Applying the FAIR4Health Solution to Identify Multimorbidity Patterns and Their Association with Mortality through a Frequent Pattern Growth Association Algorithm
  8. Applying the FAIR4Health Solution to Identify Multimorbidity Patterns and Their Association With Mortality Through a Frequent Pattern Growth Association Algorithm
  9. Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy
  10. Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011–2015 Comparison Using Real-World Data
  11. Overuse or underuse? Use of healthcare services among irregular migrants in a north-eastern Spanish region
  12. Multimorbidity networks of chronic obstructive pulmonary disease and heart failure in men and women: Evidence from the EpiChron Cohort
  13. Training primary care professionals in multimorbidity management: Educational assessment of the eMULTIPAP course
  14. Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients
  15. Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients
  16. <p>Chronic Obstructive Pulmonary Disease and Incidence of Hip Fracture: A Nested Case–Control Study in the EpiChron Cohort</p>
  17. Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study
  18. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study
  19. Influenza Vaccination: An Ally to Mitigate Influenza-associated Risks During the Coronavirus Disease 2019 (COVID-19) Pandemic
  20. Assessing the Pilot Implementation of the Integrated Multimorbidity Care Model in Five European Settings: Results from the Joint Action CHRODIS-PLUS
  21. Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain
  22. Multimorbidity and chronic diseases among undocumented migrants: evidence to contradict the myths
  23. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study
  24. Multimorbidity Patterns in the General Population: Results from the EpiChron Cohort Study
  25. Prevalence and Comorbidity of Atopic Dermatitis in Children: A Large-Scale Population Study Based on Real-World Data
  26. Initial Therapy, Regimen Change, and Persistence in a Spanish Cohort of Newly Treated Type 2 Diabetes Patients: A Retrospective, Observational Study Using Real-World Data
  27. Do Centenarians Die Healthier than Younger Elders? A Comparative Epidemiological Study in Spain
  28. Sex Differences in Comorbidity, Therapy, and Health Services’ Use of Heart Failure in Spain: Evidence from Real-World Data
  29. Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study
  30. Application of the JA-CHRODIS Integrated Multimorbidity Care Model (IMCM) to a Case Study of Diabetes and Mental Health
  31. A Methodological Approach for Implementing an Integrated Multimorbidity Care Model: Results from the Pre-Implementation Stage of Joint Action CHRODIS-PLUS
  32. Multimorbidity patterns in patients with heart failure: an observational Spanish study based on electronic health records
  33. Treatment Patterns of Diabetes in Italy: A Population-Based Study
  34. Adherencia al tratamiento de hipertensión arterial, hipercolesterolemia y diabetes en población anciana de una cohorte española
  35. Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources
  36. Health care services use among long-term breast cancer survivors: a systematic review
  37. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators
  38. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case–Control Study Using Automated Health Data Sources
  39. The definition of immigrant status matters: impact of nationality, country of origin, and length of stay in host country on mortality estimates
  40. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis
  41. Free Thyroxine Determination in the Emergency Department Is a Predictor of Acute Pancreatitis Evolution
  42. Adherence to chronic medication in older populations: application of a common protocol among three European cohorts
  43. Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany
  44. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort
  45. Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study
  46. Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS)
  47. Multimorbidity and immigrant status: associations with area of origin and length of residence in host country
  48. Multimorbilidad en medicina de familia y los principios Ariadne. Un enfoque centrado en la persona
  49. Hacia un modelo de atención a la multimorbilidad en atención primaria
  50. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project)
  51. Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany
  52. Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization
  53. Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA
  54. Concordancia del registro de demencia en las principales fuentes de información clínica
  55. Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board
  56. Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification
  57. Global healthcare use by immigrants in Spain according to morbidity burden, area of origin, and length of stay
  58. Poor congruence with guidelines in the use of antibiotics for acute bronchitis: a descriptive study based on electronic health records
  59. Baja concordancia entre la información clínica de atención primaria y hospital
  60. Non-adherence to antihypertensive medication: The role of mental and physical comorbidity
  61. Patterns of pharmaceutical use for immigrants to Spain and Norway: a comparative study of prescription databases in two European countries
  62. Multimorbidity: Epidemiology and Models of Care
  63. Armonización de bases de datos para el estudio de la fragilidad en personas mayores: Estudio INTAFRADE
  64. Multimorbidity and Its Patterns according to Immigrant Origin. A Nationwide Register-Based Study in Norway
  65. Multimorbidity among registered immigrants in Norway: the role of reason for migration and length of stay
  66. Multimorbidity Patterns in Hospitalized Older Patients: Associations among Chronic Diseases and Geriatric Syndromes
  67. Chronic conditions, disability, and quality of life in older adults with multimorbidity in Spain
  68. Global health care use by patients with type-2 diabetes: Does the type of comorbidity matter?
  69. Multimorbidity and weight loss in obese primary care patients: longitudinal study based on electronic healthcare records
  70. The healthy migrant effect in primary care
  71. Interventional Tools to Improve Prescription and Adherence to Medical Plans
  72. The Ariadne principles: how to handle multimorbidity in primary care consultations
  73. Primary health care use from the perspective of gender and morbidity burden
  74. Frequent attenders in general practice and immigrant status in Norway: A nationwide cross-sectional study
  75. Association between physical activity, multimorbidity, self-rated health and functional limitation in the Spanish population
  76. How do immigrants use primary health care services? A register-based study in Norway
  77. Similar Multimorbidity Patterns in Primary Care Patients from Two European Regions: Results of a Factor Analysis
  78. Age and gender differences in the prevalence and patterns of multimorbidity in the older population
  79. Does higher quality of primary healthcare reduce hospital admissions for diabetes complications? A national observational study
  80. Comorbidity of dementia: a cross-sectional study of primary care older patients
  81. Multimorbidity patterns: a systematic review
  82. Morbilidad y consumo de fármacos. Comparación de resultados entre la Encuesta Nacional de Salud y los registros electrónicos
  83. Polypharmacy Patterns: Unravelling Systematic Associations between Prescribed Medications
  84. Correction: Multimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor Analysis
  85. Relationship between efficiency and clinical effectiveness indicators in an adjusted model of resource consumption: a cross-sectional study
  86. Morbilidad y coste asociado a los trastornos neurológicos
  87. Morbidity and costs associated with neurological disorders
  88. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
  89. Comparación entre tres métodos de medida de la multimorbilidad en función del uso de recursos sanitarios en atención primaria
  90. Obtaining the mean relative weights of the cost of care in Catalonia (Spain): retrospective application of the adjusted clinical groups case-mix system in primary health care
  91. Distribución del gasto sanitario en atención primaria según edad y sexo: un análisis retrospectivo
  92. Multimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor Analysis
  93. Influencia de la comorbilidad crónica sobre el coste sanitario
  94. Adaptive capacity of the Adjusted Clinical Groups Case-Mix System to the cost of primary healthcare in Catalonia (Spain): a observational study
  95. Frecuentación de la población inmigrante versus autóctona en atención primaria: ¿quién consume más servicios?
  96. Estimación de la comorbilidad crónico sobre el costo sanitario en pacientes ancianos con transtornos neurológicos
  97. Bárbara Starfield. Necrológica
  98. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study
  99. Primary care utilisation patterns among an urban immigrant population in the Spanish National Health System
  100. Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure
  101. Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: The impact of a local calibration
  102. Utilización de los grupos clínicos ajustados en un centro de atención primaria español: estudio retrospectivo de base poblacional
  103. Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals
  104. Identificación de pacientes hiperconsumidores de farmacia en atención primaria
  105. The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases
  106. Variations in health services utilization by primary care patients
  107. The Influence of psychological and social factors on accuracy of self-reported blood pressure
  108. Características de Los No Respondientes a un Estudio de Seguimiento en Mayores de 65 Años